Company · CIK 0001603454 · SIC 8071 — Services-Medical Laboratories · Nasdaq
Celcuity Inc. · CELC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 AForm 4 → | Aug 18, 4:19 pm EDT | Lance G. LaingChief Science Officer, Director | 20,000 | — | — | 1,271,000 | — | |
| Aug 14, 2026 AForm 4 → | Aug 18, 4:18 pm EDT | Brian F. SullivanChief Executive Officer, Director | 80,000 | — | — | 1,450,199 | — | |
| Aug 14, 2026 AForm 4 → | Aug 18, 4:17 pm EDT | Vicky HahneChief Financial Officer | 16,000 | — | — | 37,808 | — | |
| Jul 14, 2026 SForm 4 → | Jul 16, 5:42 pm EDT | BAKER BROS. ADVISORS LP +3Other | 3,100,000 | $102.50 | $317,750,000 | 4,372,852 | −41.5% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 AForm 4 → | Aug 18, 4:19 pm EDT | Lance G. LaingChief Science Officer, Director | 10,000 | — | — | 10,000 | — | |
| Aug 14, 2026 AForm 4 → | Aug 18, 4:18 pm EDT | Brian F. SullivanChief Executive Officer, Director | 120,000 | — | — | 120,000 | — | |
| Aug 14, 2026 AForm 4 → | Aug 18, 4:17 pm EDT | Vicky HahneChief Financial Officer | 10,000 | — | — | 10,000 | — |